GT Biopharma (OXIA.F) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.71
-0.51
-0.3
-0.09

Details

Expected EPS
-0.09462090000000001
Actual EPS
-0.09462090000000001
Surprise EPS
0
Surprise Percent
+0%

Description

GT Biopharma (OXIA.F) has reported earnings of -0.09462090000000001 per share for Q2 2026.

0 Comments

Share your thoughts